Altre lingue Bionano Genomics, Inc.

Azioni

BNGO

US09075F3055

Tempo reale stimato Cboe BZX Altri mercati azionari 19:29:10 09/07/2024			Variaz. 5gg	Var. 1 gen.
0,635 ^USD	+14,66%		+17,20%	-64,64%

08/07	Bionano Genomics raccoglie 10 milioni di dollari da un'offerta diretta	MT
05/07	Aggiornamento settoriale: i titoli del settore sanitario avanzano nel tardo pomeriggio	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bionano Genomics Raises $10 Million From Direct Offering	08/07
Sector Update: Health Care Stocks Advance Late Afternoon	05/07
Bionano Genomics to Sell Shares in Direct Offering	05/07
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	05/07
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting	02/07
Bionano Genomics Says Revvity to Commercialize VIA Software	20/06
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research	20/06
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis	17/06
Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow	30/05
Bionano Genomics Raises $18 Million From Private Debentures Placement	28/05
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet	28/05
Bionano Genomics, Inc. announced that it has received $18 million in funding	24/05
Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy	21/05
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis	09/05
Bionano Genomics, Inc. Announces Significant Upgrades to its Suite of Computational Tools for Comprehensive Cancer Analysis	09/05
Bionano Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress	08/05
Bionano Genomics, Inc. Provides Revenue Guidance for the Second Quarter of 2024 and Reiterated Revenue Guidance for the Year 2024	08/05
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	01/05
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	30/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bionano Genomics, Inc.

Azioni

BNGO

US09075F3055

Altre lingue

Filtri